We all know that plants and fungi can help us to stay healthy and reduce our risk of disease, but they can also be a source of health issues that can interfere with our overall health.
According to a new report from the Institute for Medicinal Plants, the majority of plant-based medicines are used by people who have serious ailments, including cancer and other diseases.
And for many people, they can be harmful.
“We have found that nearly 70% of the products sold in the United States have adverse health effects, which is a high proportion of products,” said Dr. David J. Kowalski, the executive director of the Institute.
“This is because these products may be mislabeled, they may contain ingredients that are toxic, or they may be made from plants that are harmful to health.
These adverse health risks can interfere directly with the quality of a patient’s health care.”
Kowalskis research team studied the impact of medicinal plants on health and concluded that the products can be potentially harmful if used incorrectly.
“There is no evidence that medicinal plants are safe or effective in treating a particular condition,” he said.
“We also found that most of these products are mislabeling their intended uses and using ingredients that have not been scientifically evaluated.”
For example, the Institute found that, of the more than 10,000 products the researchers examined, about 3,700 were labeled as containing “flavors of cannabis.”
While some of these could potentially be considered cannabis-based products, most of them do not.
Instead, the researchers used a botanical analysis tool called BAC-TOF to examine the ingredients and chemical structure of the cannabis products, which were extracted from the cannabis plant, which contains the active chemical compounds known as cannabinoids.
These compounds are present in all types of plant and plant species.
The study found that in a large percentage of these cannabis-derived products, the plant was actually derived from the bark of a medicinal plant.
For example, more than half of the medicinal plants were derived from a medicinal leaf called bhang, which grows naturally in India.
Other products, like the popular medicinal ginger, were derived entirely from the resin extracted from cannabis leaves.
For many people these are the only products that they are exposed to that are used in a safe and effective manner.
The Institute also found a lot of medicinal products have little or no data on safety and effectiveness.
For instance, the products that are marketed as medicinal ginger are not even tested on humans, meaning the manufacturers may be concealing dangerous chemicals from the consumer.
While the researchers found that about 70% to 90% of cannabis products marketed as being effective for treating cancer and cardiovascular diseases are either mislabeleds or are not safe, only about 30% of products that actually provide the benefit actually do, according to the Institute report.
In addition, many of these herbal products contain ingredients like flavoring, which can be toxic to some people.
“The FDA’s position on the safety of medicinal cannabis products is inconsistent,” said Kowalas research team.
“As a result, we believe the agency should consider taking a closer look at the safety and efficacy of medicinal cannabinoids.”
A growing number of health experts are calling for the FDA to ban the use of medicinal marijuana.
In January, the American Medical Association released a statement calling for a ban on the use and distribution of cannabis-infused products.
“It is imperative that the FDA review the safety data on these products and review their marketing practices to ensure that products are safe and beneficial to the public,” said AMA Executive Vice President of Health and Medical Policy Dr. Michael Abrams.
The American Academy of Pediatrics has also called for the ban on cannabis.
“I think it’s a very good thing that the American Academy is finally recognizing this,” said James Kogan, a pediatrician at Johns Hopkins University.
“There’s a lot that needs to be done to regulate and regulate this, and I think it has an enormous role to play in the fight against this.”
He added that a ban will prevent young people from becoming addicted to cannabis and will also save lives.
“People will be less likely to get addicted to it,” Kogan said.
The National Cannabis Industry Association, which represents many cannabis industry companies, has also launched a campaign calling for regulation of medicinal and recreational cannabis.
The FDA is also considering banning cannabis-containing products.
The cannabis industry has been struggling to compete in a highly competitive market.
The federal government is currently considering a plan to make medical cannabis products less expensive and easier to access.